Amgen Inc
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen MVASI (bevacizumab-awwb by Year
MVASI (bevacizumab-awwb — Avastin Oncology Biosimilar) — U.S. product sales ($M) ($M)
Amgen MVASI (bevacizumab-awwb: $573M in FY2025, up 27.6% from a year earlier.
Latest, FY2025
573
Period ended Dec 31, 2025
Change on a year earlier
+27.6%
449 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Where the FY2025 figure comes from
“|| MVASI — U.S. | $ | 573 | 28 | % | $ | 449 | (12) | % | $ | 511”
Source: Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗
Reported in Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Product Sales Detail.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | MVASI (bevacizumab-awwb — Avastin Oncology Biosimilar) — U.S. product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 573 | +27.6% | Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 449 | -12.1% | Form 10-K (amgn-20241231.htm, filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | 511 | -15.1% | Form 10-K (amgn-20231231.htm, filed 2024-02-14) ↗ |
| FY2022 | Dec 31, 2022 | 602 | -27.1% | Form 10-K (amgn-20221231.htm, filed 2023-02-09) ↗ |
| FY2021 | Dec 31, 2021 | 826 | +25.9% | Form 10-K (amgn-20211231.htm, filed 2022-02-16) ↗ |
| FY2020 | Dec 31, 2020 | 656 | +442.1% | Form 10-K (amgn-20201231.htm, filed 2021-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 121 | – | Form 8-K (amgn-20191231xq4ex991.htm, filed 2020-01-30) ↗ |
Cite this data
StockData. (2026). Amgen MVASI (bevacizumab-awwb ($M), annual FY2019–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod-mvasi-us
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.